NBC19: Precision NLRP3 Inflammasome Inhibitor for Inflamm...

2025-10-21

NBC19 empowers researchers to dissect and modulate the NLRP3 inflammasome signaling pathway with sub-100 nM potency, providing robust suppression of IL-1β release in THP1 cell assays. Its reliability in both Nigericin- and ATP-induced inflammasome activation systems, along with advanced troubleshooting strategies, sets a new benchmark for reproducible inflammation research.